ALMR EMEA — Revenue increased by 179.3% to $3.97M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful expansion and growing demand for the company's proteomics solutions within the EMEA market, while a decrease may signal competitive pressure or challenges in regional distribution and adoption.
This metric represents the total revenue generated from contracts with customers located within the Europe, Middle East,...
Peers in the life sciences and diagnostics sector typically report regional revenue to demonstrate global commercial scaling, with growth rates often benchmarked against regional healthcare R&D spending trends.
almr_segment_emea_revenue_from_contract_with_customer_excluding_assessed_tax| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $1.42M | $3.97M |
| QoQ Change | — | +179.3% |
| YoY Change | — | +179.3% |